GSK Annual Report 2002

Share capital GlaxoSmithKline 155
Analysis of shareholdings
Analysis of shareholdings at 31st December 2002:
Number of
accounts
% of total
accounts
% of total
shares
Number of
shares
Holding of shares
Up to 1,000 175,952 69.8 1.1 64,763,266
1,001 to 5,000 57,887 23.0 2.1 125,349,601
5,001 to 100,000 16,231 6.5 4.1 250,388,993
100,001 to 1,000,000 1,370 0.5 7.2 433,591,515
Over 1,000,000 503 0.2 85.5 5,150,172,970
Totals 251,943 100.0 100.0 6,024,266,345
Held by
Nominee companies 66,402 26.4 84.9 5,113,657,689
Investment and trust companies 374 0.1 0.2 10,383,896
Insurance companies 39 – 0.9 52,529,770
Individuals and other corporate bodies 185,127 73.5 5.0 301,540,855
BNY (Nominees) Limited 1 – 9.0 546,154,135
Totals 251,943 100.0 100.0 6,024,266,345
The Bank of New York’s holding held through BNY (Nominees) Limited represents the company’s ADR programme, whereby each ADS
represents two Ordinary Shares of 25p nominal value.
At 3rd March 2003, the number of holders of record of shares in the USA was 1,178 with holdings of 1,845,570 shares, and
the number of registered holders of the ADRs was 49,956 with holdings of 272,882,770 ADRs. Certain of these shares and ADRs were
held by brokers or other nominees, as a result the number of holders of record or registered holders in the USA is not representative of
the number of beneficial holders or of the residence of beneficial holders.
Control of company
As far as is known to the company, it is not directly or indirectly owned or controlled by one or more corporations or by any government.
The company does not know of any arrangements, the operation of which might result in a change in control of the company.
Substantial shareholdings
At 3rd March 2003, the company had received notification of the following interest of three per cent or more in its shares:
• BNY (Nominees) Limited holds 545,773,383 shares representing 9.07 per cent. These shares are held on behalf of holders of American
Depositary Receipts, which evidence American Depositary Shares
• Legal & General Investment Management Limited holds 186,857,268 shares representing 3.1 per cent
• Barclays plc holds 180,980,055 shares representing 3.0 per cent.
As far as is known to the company, no other person was the owner of three per cent or more of the shares of the company.
Directors and Officers
The interests of the Directors and Officers of the company (as defined in the Companies Act 1985) in share options of the company are
given in the ‘Remuneration report’ (pages 39 to 50).
Exchange controls and other limitations affecting security holders
There are currently no UK laws, decrees or regulations restricting the import or export of capital or affecting the remittance of dividends
or other payments to holders of the company’s shares who are non-residents of the UK. There are no limitations relating only to
non-residents of the UK under English law or the company’s Memorandum and Articles of Association on the right to be a holder of,
and to vote in respect of, the company’s shares.